Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $60.00
- 52-wk high
- $86.74
- High
- $60.41
- 52-wk low
- $41.70
- Low
- $58.61
- Prev close
- $60.80
Smart money
Earnings
Earnings came in $1.79 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $156.7M | $203.0M | $246.1M | $267.9M |
| Cost of what it sold | $2.3M | $8.0M | $3.0M | $2.7M |
| Gross profit | $154.4M | $195.0M | $243.1M | $265.2M |
| What it spent | ||||
| Research and development | $217.8M | $280.0M | $210.2M | $217.1M |
| Sales and admin | $96.8M | $130.2M | $150.4M | $150.4M |
| Total operating expenses | $314.6M | $410.0M | $360.5M | $367.5M |
| What was left | ||||
| Operating profit | -$160.2M | -$215.0M | -$117.4M | -$102.3M |
| Interest on debt | $22.2M | $22.7M | $22.5M | $22.1M |
| Profit before tax | -$128.4M | -$228.0M | -$92.3M | -$113.4M |
| Tax | $213.0K | $1.0M | $218.0K | -$1.3M |
| Net profit | -$128.6M | -$229.0M | -$92.5M | -$114.6M |
| EBITDA | -$103.3M | $4.61B | -$68.5M | -$105.3M |
Technicals
Price structure
This stock's price action is mixed, and looks overbought after a fast run-up.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Ionis Pharmaceuticals, Inc. $IONS Shares Bought by Handelsbanken Fonder AB
Leans bullishAug 12(IONS) Price Dynamics and Execution-Aware Positioning
Leans bullishAug 11IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law
BearishAug 8